Home › Encyclopedia › Cerebrolysin: Research Status And Trial Overview
Research / Unapproved

Cerebrolysin: Research Status And Trial Overview

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Registered trials42

Key takeaways

  • Cerebrolysin has no FDA-approved label and is classified as an investigational compound in research settings.
  • No pharmacology, indication, or mechanism data from an approved label exists for this compound.
  • At least 42 trials involving cerebrolysin are registered on ClinicalTrials.gov.
  • Sampled trials span stroke recovery and upper limb rehabilitation research, with statuses ranging from unknown to terminated.

What cerebrolysin is

Cerebrolysin is studied as an investigational compound and does not carry an FDA-approved label. Because no approved label exists, there is no FDA-sanctioned description of its composition, mechanism, or intended use available here.

Trial footprint

Registries list 42 trials involving cerebrolysin. One trial, CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke, examines effects around the blood-brain barrier in acute ischemic stroke, though its status is listed as unknown. Another, Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT, looks at early use in acute stroke patients undergoing endovascular therapy and is also listed as unknown status. A third trial, IMPULSE, studied stimulation of brain plasticity to improve upper limb recovery after stroke but was terminated.

FAQ

Is cerebrolysin FDA-approved?
No. Cerebrolysin is not FDA-approved and carries no approved label in the United States. It is studied as an investigational compound in clinical research settings.
What conditions is cerebrolysin being studied for?
Registered trials have examined cerebrolysin in the context of acute ischemic stroke and post-stroke upper limb recovery. These are research studies and do not establish that cerebrolysin is effective for any condition.
How many clinical trials involve cerebrolysin?
At least 42 trials involving cerebrolysin are registered on ClinicalTrials.gov. Sampled trials include studies on stroke recovery and brain plasticity, with varying statuses including unknown and terminated.
Has any cerebrolysin trial been completed successfully?
The sampled trials show a range of statuses, including unknown and terminated, rather than confirmed completion with positive results. This data reflects trial status only and does not indicate whether cerebrolysin works for any purpose.
Are there known side effects of cerebrolysin?
No adverse event report data is available for cerebrolysin in this overview. Because no approved label or adverse event dataset exists here, side effect information cannot be summarized.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: ClinicalTrials.gov

Updated 2026-08-03